广发创新药ETF联接C
(012738.jj ) CS创新药 (半年) 广发基金管理有限公司
基金经理罗国庆基金类型指数型基金(ETF,联接型)成立日期2021-07-07总资产规模9.60亿 (2025-12-31) 基金净值0.6083 (2026-04-16) 管理费用率0.50%管托费用率0.10% (2025-06-10) 成立以来分红再投入年化收益率-9.89% (5602 / 5786)
备注 (0): 双击编辑备注
发表讨论

广发创新药ETF联接C(012738) - 历史月度涨跌幅

数据选项
基金名称1月2月3月4月5月6月7月8月9月10月11月12月年度涨跌幅年度超额收益率
2026广发创新药ETF联接C 0.38%-1.77%-0.10%5.41%----------------3.82%-0.38%
CS创新药 0.46%-1.82%-0.07%5.72%----------------4.20%
2025广发创新药ETF联接C -2.56%5.29%3.19%-0.81%7.56%0.05%15.99%2.82%1.79%-4.76%-4.40%-4.78%18.94%-0.40%
CS创新药 -2.75%5.67%3.38%-0.84%7.71%-0.22%16.85%2.99%1.84%-5.03%-4.69%-4.98%19.34%
2024广发创新药ETF联接C -21.63%13.12%-4.13%0.79%-5.16%-7.36%3.86%-3.25%21.60%-5.42%2.95%-5.41%-15.32%1.20%
CS创新药 -22.60%13.91%-4.37%0.87%-5.82%-8.03%3.91%-3.59%23.05%-5.49%3.11%-5.64%-16.51%
2023广发创新药ETF联接C 7.31%-2.56%-5.92%-0.08%-4.70%-5.29%2.28%-4.50%5.28%3.53%0.70%-6.12%-10.70%1.21%
CS创新药 7.74%-2.72%-6.31%-0.10%-5.16%-5.99%2.25%-4.88%5.62%3.77%0.85%-6.31%-11.91%
2022广发创新药ETF联接C -15.95%3.02%3.21%-14.14%-0.35%12.83%-8.79%-2.94%-9.28%5.47%4.27%-0.53%-24.21%1.53%
CS创新药 -16.93%3.32%3.53%-15.03%-0.53%13.49%-9.47%-3.22%-9.93%5.95%4.80%-0.56%-25.74%
2021广发创新药ETF联接C -------------2.67%-7.29%3.81%-4.30%2.14%-6.13%-14.05%-3.44%
CS创新药 1.53%-1.81%-1.70%13.41%0.90%-1.38%-7.62%-7.98%4.11%-4.53%2.26%-6.44%-10.61%
2020广发创新药ETF联接C ----------------------------
CS创新药 5.10%2.60%-1.68%8.67%5.02%17.80%21.02%-6.19%-10.14%3.35%-8.84%13.24%55.14%
2019广发创新药ETF联接C ----------------------------
CS创新药 -------0.87%-7.68%4.22%2.58%8.55%-2.46%6.32%-2.07%3.13%11.24%